ArticleDiscover nano2025
Sustainable fabrication of TIF@ZIF-8 nanocomposites: characterization, antioxidant potential, and bioactive applications.
Article in Discover nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The exploration of advanced delivery systems for natural antioxidants is crucial for enhancing their bioavailability and therapeutic efficacy. Metal-organic frameworks, particularly zeolitic imidazolate frameworks (ZIFs), offer promising solutions due to their tunable pore structures, robust chemical stability, and customizable surface functionalities, making them ideal candidates for drug delivery and the encapsulation of bioactive compounds. This study aimed to encapsulate Tamarindus indica L. (TIF) flower extract into ZIF-8 using a Nano-precipitation method to develop the TIF@ZIF-8 nanocomposite with enhanced antioxidant and antimicrobial properties. The TIF@ZIF-8 nanocomposite was synthesized via Nano-precipitation. Antioxidant activity was evaluated using DPPH radical scavenging and lipid peroxidation inhibition assays. The phytochemical composition, physicochemical properties were performed following standard protocols. A qualitative fingerprint of TIF was analyzed using high-performance thin layer chromatography. The key phytoconstituents were identified using gas chromatography-mass spectrometry (GC-MS). Structural and morphological characterizations of the nanocomposite were performed using powder X-ray diffraction, scanning electron microscopy, transmission electron microscopy, and thermal gravimetric analysis. The TIF@ZIF-8 nanocomposite demonstrated significant antioxidant activity with a DPPH scavenging rate of 72.54% and lipid peroxidation inhibition of 69.14%, outperforming Vitamin C and BHT. The IC50 values for DPPH and lipid peroxidation inhibition were 64.14 µg/mL and 57.74 µg/mL, respectively. GC-MS identified key bioactive compounds, including Isobutylene epoxide and Ethyl leucinate. This study demonstrates the potential of ZIF-8 as a carrier for bioactive plant compounds. The TIF@ZIF-8 nanocomposite shows promising antioxidant property, with potential applications in targeted drug delivery, therapeutic formulations, and antioxidant therapies, contributing to advanced nanomaterial design for health and wellness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.